Omental flap for recurrent deep sternal wound infection and mediastinitis after cardiac surgery

Thorac Cardiovasc Surg. 2007 Sep;55(6):371-4. doi: 10.1055/s-2007-965305.

Abstract

Background: Unsuccessful surgical treatment of deep sternal wound infection (DSWI) and mediastinitis may lead to sepsis, multiorgan failure and death. Omental flap transposition (OFT) may, in this situation, be the only effective therapy.

Methods: Twenty-seven patients with DSWI and mediastinitis after one or more unsuccessful surgical attempts to cure the infection were treated by OFT. Forty-one interventions (1.5/patient) consisting of closed irrigation technique, bilateral pectoralis flap reconstruction and vacuum-assisted therapy were performed before carrying out OFT.

Results: Operative mortality was 0. Mean postoperative ventilation time was 1.38 days and mean time in the intensive care unit was 4.7 days. Hospital mortality was 7.4 % (n = 2). Mean follow-up time was 2 years. One patient (4 %) died one year after discharge. During follow-up, abdominal wall hernia occurred in one patient (4 %) and presternal fistula resection was necessary in another patient (4 %).

Conclusion: OFT is, in our experience, the most effective procedure for the treatment of recurrent DSWI and mediastinitis after cardiac surgery. Early mortality is acceptable, morbidity is low and late results are very good.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Cardiac Surgical Procedures / adverse effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mediastinitis / drug therapy
  • Mediastinitis / etiology
  • Mediastinitis / surgery*
  • Omentum / transplantation*
  • Recurrence
  • Retrospective Studies
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / etiology
  • Staphylococcal Infections / surgery*
  • Sternum*
  • Surgical Flaps*
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / etiology
  • Surgical Wound Infection / surgery*
  • Treatment Outcome
  • Wound Healing

Substances

  • Anti-Bacterial Agents